Industry partnership will determine the success of the transition to low-GWP pMDIs
Opinion by Darren Bromley-Davenport, Technical Manager at Orbia Fluor & Energy Materials A tightening regulatory landscape is driving the pharmaceutical…
Opinion by Darren Bromley-Davenport, Technical Manager at Orbia Fluor & Energy Materials A tightening regulatory landscape is driving the pharmaceutical…
Increasingly, generative AI is transforming how that information is analysed, summarised and shared. According to 2026 research by the Copyright…
Bringing a new drug to market is one of the most time‑consuming and costly assignments within the pharma industry. From…
While these transfers are a normal part of business, navigating them requires a strategic approach to ensure smooth and efficient…
Lupin has won the M&A and Business Expansion awards in the 2025 Pharmaceutical Technology Excellence Awards, recognizing the company's strategic expansion in Europe and commitment to addressing…
1. Edwin Stone, CEO, Cellular Origins, explains what winning the Innovation award for Manufacturing Automation means for him and for…
Pharmaceutical companies are striving to balance complex and evolving regulatory demands, operational efficiency challenges, and environmental responsibility in an age…
Over the past few decades, the pharmaceutical industry has seen a steady shift toward parenteral self-administration and home-based care. As…
While surveillance data from 2024 shows an encouraging reduction in HIV transmissions1, more needs to be done to meet the…
Every year, millions of disposable gowns end up in medical waste incinerators. But a new generation of sustainable textiles is…